Dexrazoxane warrants further investigation for its cardioprotective action against anthracycline cardiotoxicity beyond simple iron chelation.
Dexrazoxane may be the key to the enigma of anthracycline cardiotoxicity, and therefore it warrants further investigation, including the search for alternative/complementary modes of cardioprotective action beyond simple iron chelation.
Štěrba et al. (2012) studied this question.